marginally non-significantp = 0.06
14% (40/286)), albeit with a marginally non-significant difference ( p = 0.06) ( Table 2 ).
14% (40/286)), albeit with a marginally non-significant difference ( p = 0.06) ( Table 2 ).
Between 2010 and 2021, the rate of resistance to streptomycin and rifampicin ranged from 14.3% to 40.0% and from 8.0% to 26.3%, respectively, showing an increasing trend year by year.